VKTX Viking Therapeutics, Inc.
Company Analysis
Latest News
🔴 Viking Therapeutics is trading 5% down today amid biotech-sector weakness
Viking Therapeutics is trading at $26.04 (-4.86%) amid biotech-sector pressure and broader-market weakness. - Biotech ETF XBI is down 2.06%. - No negative...
Viking Therapeutics Gains Strong Buy Upgrade and UBS Buy Rating
Viking Therapeutics received two positive analyst calls on Thursday. Barclays upgraded the stock to Strong Buy, while UBS Group initiated coverage with a Buy...
🟢 Viking Therapeutics is trading 5% up today amid biotech-sector strength
Viking Therapeutics is trading at $26.83, up 5.06%, amid strength in the biotech sector. - XBI is up 2.20%, the clearest available context for the move;...
🔴 Viking Therapeutics is trading 4.13% down today as hotter-than-expected inflation revives rate concerns
Viking Therapeutics is trading at $25.55, down 4.13%, during the October 14 session as hotter-than-expected September inflation revived interest-rate...
🔴 Viking Therapeutics is trading 4.38% down amid broader biotech weakness
Viking Therapeutics is trading 4.38% down at $27.10 on October 13, 2026, consistent with broader biotech weakness, though available reporting does not...
Viking Starts Oral VK2735 Study as Phase 3 Trials Reach Full Enrollment
Viking Therapeutics has started a new exploratory study of oral maintenance dosing for its obesity drug candidate, VK2735. The study is part of a broader...
🔴 Viking Therapeutics is trading 4.3% down today as XBI falls 2.04%
Viking Therapeutics is trading at $27.32, down 4.27%, amid weakness in biotech shares. - The XBI is down 2.04%; no fresh company-specific announcement...
🔴 Viking Therapeutics is trading 4.04% down today with no fresh company-specific catalyst identified
Viking Therapeutics is trading 4.04% down at $31.28; no new company-specific announcement was found for October 1. - A recent $548 million stock and...
🟢 Viking Therapeutics is trading 4.09% up today as major U.S. indexes rise
Viking Therapeutics is trading 4.09% higher at $33.11, alongside gains in major U.S. indexes. - The Nasdaq Composite is up 1.05%, while the S&P 500 has gained...
🔴 Viking Therapeutics is trading 4% down today as upsized stock and convertible-note offerings closed
Viking Therapeutics is trading at $31.70, down 4.04%; its September 29 decline followed the closing of its upsized stock and convertible-note offerings. - The...
Viking Therapeutics Raises ~$548M via Concurrent Equity and Convertible Note Offerings
Viking Therapeutics announced the closing of concurrent public offerings of common stock and convertible senior notes, raising combined net proceeds of...
🔴 Viking Therapeutics is trading 4.78% down today after $500 million financing priced shares at $35.00
Viking Therapeutics is trading 4.78% down at $33.86 as investors digest its $500 million stock-and-convertible-notes financing. - Announced September 24, the...
🔴 Viking Therapeutics is trading 4.1% down today after pricing a discounted $500 million financing
Viking Therapeutics is trading at $35.24, down 4.11%, as financing pressure weighs on the shares. - On September 24, the company priced a $500 million...
🔴 Viking Therapeutics is trading 12.64% down today as below-market shares heighten dilution concerns
Viking Therapeutics is trading at $36.38, down 12.64%, as financing terms heightened dilution concerns. - On September 24, 2026, it priced an upsized $500...
🔴 Viking Therapeutics is trading 10.18% down in pre-market after announcing $400 million in stock and notes
Viking Therapeutics is trading 10.18% down at $37.41 after announcing on September 23, 2026, separate proposed offerings: $200 million in common stock and $200...
🔴 Viking Therapeutics is trading 8% down in pre-market after proposing $400 million in separate offerings
Viking Therapeutics is trading 8% down at $38.30 after announcing financing plans that likely increased dilution concerns. - On September 23, 2026, the company...
🔴 Viking Therapeutics is trading 8.5% down in after-hours trading as investors lock in gains after 35.67% rally
Viking Therapeutics is trading 8.5% lower at $38.10 in after-hours trading, as investors reportedly digest gains and lock in profits. - Shares closed...
🟢 Viking Therapeutics is trading 4.2% up today after VK2735 data showed weight-loss retention
Viking Therapeutics is trading 4.24% up at $42.58 as investors continue reacting to positive VK2735 maintenance-study results released September 22, 2026. -...
🔴 Viking Therapeutics is trading 5% down today on apparent profit-taking after September 22 surge
Viking Therapeutics is trading 5.07% down now at $38.78 as investors appeared to take profits after the September 22 surge. - VK2735 maintenance-study data...
Viking's Obesity Drug Keeps the Weight Off With Fewer Shots — But Can a $4 Billion Biotech With Zero Revenue Justify the Hype?
Shares of Viking Therapeutics surged as much as 40% premarket before settling around $37.10 (+23.2%) after the company reported that its experimental obesity...